Ethinyl estradiol; segesterone acetate - Generic Drug Details
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What are the generic drug sources for ethinyl estradiol; segesterone acetate and what is the scope of freedom to operate?
Ethinyl estradiol; segesterone acetate
is the generic ingredient in one branded drug marketed by Therapeuticsmd Inc and is included in one NDA. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.Ethinyl estradiol; segesterone acetate has ten patent family members in ten countries.
One supplier is listed for this compound.
Summary for ethinyl estradiol; segesterone acetate
International Patents: | 10 |
US Patents: | 6 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 2 |
DailyMed Link: | ethinyl estradiol; segesterone acetate at DailyMed |
Recent Clinical Trials for ethinyl estradiol; segesterone acetate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
TherapeuticsMD | Phase 1 |
See all ethinyl estradiol; segesterone acetate clinical trials
Pharmacology for ethinyl estradiol; segesterone acetate
Drug Class | Estrogen Progestin |
Mechanism of Action | Estrogen Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for ethinyl estradiol; segesterone acetate
US Patents and Regulatory Information for ethinyl estradiol; segesterone acetate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Therapeuticsmd Inc | ANNOVERA | ethinyl estradiol; segesterone acetate | RING;VAGINAL | 209627-001 | Aug 10, 2018 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
Therapeuticsmd Inc | ANNOVERA | ethinyl estradiol; segesterone acetate | RING;VAGINAL | 209627-001 | Aug 10, 2018 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Therapeuticsmd Inc | ANNOVERA | ethinyl estradiol; segesterone acetate | RING;VAGINAL | 209627-001 | Aug 10, 2018 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ethinyl estradiol; segesterone acetate
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
South Korea | 20220027979 | 산아 제한을 제공하기 위한 시스템 | See Plans and Pricing |
Colombia | 2021017509 | Sistema para proporcionar control de la natalidad | See Plans and Pricing |
Argentina | 120976 | SISTEMA PARA PROPORCIONAR UN CONTROL DE LA NATALIDAD | See Plans and Pricing |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ethinyl estradiol; segesterone acetate
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1453521 | 93156 | Luxembourg | See Plans and Pricing | PRODUCT NAME: LEVONORGESTREL ET ETHINYLESTRADIOL; FIRST REGISTRATION DATE: 20150211 |
0771217 | CA 2006 00038 | Denmark | See Plans and Pricing | PRODUCT NAME: ETHINYLESTRADIOL (SOM BETA-CYCLODEXTRIN-CLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 38687 20060627; FIRST REG. NO/DATE: EU RVG 31781 20050804 |
0136011 | 2000C/027 | Belgium | See Plans and Pricing | PRODUCT NAME: ETHINYLESTRADIOLUM / NORETHISTERONI ACETAS; NAT. REGISTRATION NO/DATE: 19 IS 106 F3 20000911; FIRST REGISTRATION: NL RVG 23909 19991124 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.